Oncology Clinical Trials: Active Studies by Market and Country

• 47markets with active trials
• 23,401active studies on Oncology/Cancer Drugs
• 42of our places with active trials

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

1. 1Oncology/Cancer Drugs23,401Oncology/Cancer Drugs: See them on ClinicalTrials.gov (opens in a new tab)
2. 2Cell Based Immunotherapy21,325Cell Based Immunotherapy: See them on ClinicalTrials.gov (opens in a new tab)
3. 3Breast Cancer Therapeutics4,498Breast Cancer Therapeutics: See them on ClinicalTrials.gov (opens in a new tab)
4. 4Breast Cancer Diagnostic4,306Breast Cancer Diagnostic: See them on ClinicalTrials.gov (opens in a new tab)
5. 5Lung Cancer4,180Lung Cancer: See them on ClinicalTrials.gov (opens in a new tab)
6. 6Lung Cancer Therapeutics4,180Lung Cancer Therapeutics: See them on ClinicalTrials.gov (opens in a new tab)
7. 7Cancer Supportive Care Drugs4,004Cancer Supportive Care Drugs: See them on ClinicalTrials.gov (opens in a new tab)
8. 8Digital Pathology Systems2,212Digital Pathology Systems: See them on ClinicalTrials.gov (opens in a new tab)
9. 9Cancer Immunotherapy2,188Cancer Immunotherapy: See them on ClinicalTrials.gov (opens in a new tab)
10. 10Prostate Cancer2,128Prostate Cancer: See them on ClinicalTrials.gov (opens in a new tab)
11. 11Prostate Cancer Therapeutics2,128Prostate Cancer Therapeutics: See them on ClinicalTrials.gov (opens in a new tab)
12. 12Brain Cancer Diagnostic1,850Brain Cancer Diagnostic: See them on ClinicalTrials.gov (opens in a new tab)
13. 13Liver Cancer1,475Liver Cancer: See them on ClinicalTrials.gov (opens in a new tab)
14. 14Oncology Nutrition1,385Oncology Nutrition: See them on ClinicalTrials.gov (opens in a new tab)
15. 15Ovarian Cancer Therapeutics1,338Ovarian Cancer Therapeutics: See them on ClinicalTrials.gov (opens in a new tab)
16. 16CAR-T Cell Therapy1,274CAR-T Cell Therapy: See them on ClinicalTrials.gov (opens in a new tab)
17. 17Bone Cancer Diagnostic1,228Bone Cancer Diagnostic: See them on ClinicalTrials.gov (opens in a new tab)
18. 18PD-1 and PD-L1 Inhibitors1,217PD-1 and PD-L1 Inhibitors: See them on ClinicalTrials.gov (opens in a new tab)
19. 19Oesophageal Cancer894Oesophageal Cancer: See them on ClinicalTrials.gov (opens in a new tab)
20. 20Oral Cancer856Oral Cancer: See them on ClinicalTrials.gov (opens in a new tab)
21. 21Cancer Registries506Cancer Registries: See them on ClinicalTrials.gov (opens in a new tab)
22. 22Biosimilar Monoclonal Antibodies456Biosimilar Monoclonal Antibodies: See them on ClinicalTrials.gov (opens in a new tab)
23. 23Cancer Vaccines410Cancer Vaccines: See them on ClinicalTrials.gov (opens in a new tab)
24. 24Childhood Cancer394Childhood Cancer: See them on ClinicalTrials.gov (opens in a new tab)
25. 25Tumor Ablation318Tumor Ablation: See them on ClinicalTrials.gov (opens in a new tab)
26. 26Precision Oncology296Precision Oncology: See them on ClinicalTrials.gov (opens in a new tab)
27. 27Liquid Biopsy291Liquid Biopsy: See them on ClinicalTrials.gov (opens in a new tab)
28. 28Bispecific Antibodies287Bispecific Antibodies: See them on ClinicalTrials.gov (opens in a new tab)
29. 29Proton Therapy285Proton Therapy: See them on ClinicalTrials.gov (opens in a new tab)
30. 30KRAS Inhibitors280KRAS Inhibitors: See them on ClinicalTrials.gov (opens in a new tab)
31. 31Antibody-Drug Conjugates269Antibody-Drug Conjugates: See them on ClinicalTrials.gov (opens in a new tab)
32. 32HPV Testing190HPV Testing: See them on ClinicalTrials.gov (opens in a new tab)
33. 33Colorectal Cancer Screening179Colorectal Cancer Screening: See them on ClinicalTrials.gov (opens in a new tab)
34. 34HPV Vaccines129HPV Vaccines: See them on ClinicalTrials.gov (opens in a new tab)
35. 35Breast Cancer Early Detection123Breast Cancer Early Detection: See them on ClinicalTrials.gov (opens in a new tab)
36. 36HPV Vaccination99HPV Vaccination: See them on ClinicalTrials.gov (opens in a new tab)
37. 37Radiopharmaceuticals85Radiopharmaceuticals: See them on ClinicalTrials.gov (opens in a new tab)
38. 38Multi-Cancer Early Detection76Multi-Cancer Early Detection: See them on ClinicalTrials.gov (opens in a new tab)
39. 39Kaposi Sarcoma40Kaposi Sarcoma: See them on ClinicalTrials.gov (opens in a new tab)
40. 40In Vivo CAR-T Therapy39In Vivo CAR-T Therapy: See them on ClinicalTrials.gov (opens in a new tab)
41. 41Cancer Treatment Access34Cancer Treatment Access: See them on ClinicalTrials.gov (opens in a new tab)
42. 42Cervical Cancer Screening and Treatment30Cervical Cancer Screening and Treatment: See them on ClinicalTrials.gov (opens in a new tab)
43. 43HIV and Cervical Cancer Screening24HIV and Cervical Cancer Screening: See them on ClinicalTrials.gov (opens in a new tab)
44. 44Smokeless Tobacco16Smokeless Tobacco: See them on ClinicalTrials.gov (opens in a new tab)
45. 45Radiotherapy Access4Radiotherapy Access: See them on ClinicalTrials.gov (opens in a new tab)
46. 46Palliative Care Access3Palliative Care Access: See them on ClinicalTrials.gov (opens in a new tab)
47. 47Colorectal Cancer Screening Programmes1Colorectal Cancer Screening Programmes: See them on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

• A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

  NCT07546500Oncology/Cancer Drugs

• A Study of QLS5132 in Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

  NCT07926048Oncology/Cancer Drugs

• Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  NCT01906385Oncology/Cancer Drugs

• Detection and Characterization of Host Defense Defects

  NCT00001355Cell Based Immunotherapy

• Retlirafusp Alfa or Adebrelimab Plus SOX as Neoadjuvant Therapy for HER2-Negative Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

  NCT07924332Cell Based Immunotherapy

• Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

  NCT01366144Breast Cancer Therapeutics

• Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  NCT05564377Breast Cancer Therapeutics

• A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

  NCT07541079Breast Cancer Therapeutics

• Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases

  NCT07619534Breast Cancer Diagnostic

• Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

  NCT06260033Breast Cancer Diagnostic

• Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

  NCT07217990Breast Cancer Diagnostic

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

  NCT06472245Lung Cancer

• M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

  NCT02595931Lung Cancer

• A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

  NCT07227597Cancer Supportive Care Drugs

• Living Well With Lymphoma

  NCT06047626Cancer Supportive Care Drugs

• Medically Tailored Meals to Improve Cancer Outcomes

  NCT07924241Cancer Supportive Care Drugs

• Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock

  NCT07762560Digital Pathology Systems

• Telegram Messenger Support for Smoking Cessation After Heart Attack

  NCT07230249Digital Pathology Systems

• Comparison of NMTCuff and Standard TOF in Gynecologic Oncology Surgery (NMTCUFF-TOF)

  NCT07925463Digital Pathology Systems

• Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

  NCT03811015Cancer Immunotherapy

• Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  NCT03866382Cancer Immunotherapy

• Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

  NCT06422806Cancer Immunotherapy

• Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

  NCT07140900Prostate Cancer

• Virtual Reality Education Before CyberKnife Treatment for Prostate Cancer

  NCT07932626Prostate Cancer

Source: ClinicalTrials.gov, Study records, newest update first. Retrieved 12 Nov 2026.

• Early deaths from long-term diseases (WHO)
• Clinical trials: Cancer
• Cancer death rate

• Diagnostics and lab testing
• Women's health
• Genomics
• Biologics and biosimilars
• Health IT and data
• Home and long-term care
• Nutrition
• Respiratory
• HIV
• Artificial intelligence